Call: (346) 633-4900
Email: info@synergygroupus.com
BROADWAY
MISSOURI CITY
SOUTHWEST
Gout is a painful and inflammatory form of arthritis characterized by sudden, severe episodes of pain, redness, and swelling in the joints. Traditionally, gout has been manageable with medications that reduce uric acid levels. However, some patients experience refractory gout, a condition where traditional treatments fail to provide relief. For these individuals, innovative solutions are not just beneficial but essential in improving their quality of life. At Synergy Groups Medical, we're at the forefront of researching new treatment methodologies for refractory gout through our dedicated clinical study. In this blog, we delve into the promising developments and invite eligible participants to join our groundbreaking study.
Gout's underlying cause is the accumulation of urate crystals in the joints due to elevated uric acid levels. In most cases, medications that lower uric acid can effectively control symptoms. Refractory gout, however, doesn't respond to these treatments, leading to persistent discomfort and a substantial impact on one's day-to-day life. Therefore, it becomes crucial to explore innovative therapies that offer hope beyond conventional methods.
The Uncontrolled Refractory Gout Clinical Study at Synergy Groups Medical is committed to evaluating a new medication regimen that holds promise for sufferers. This novel approach combines the new medication with Methotrexate, traditionally utilized for autoimmune conditions, aiming to significantly reduce immune reactions and improve symptoms. Our goal is to assess the safety and efficacy of this treatment administered every 2 to 4 weeks, providing relief to individuals with hard-to-treat gout. What sets our study apart is not only its innovative nature but also our comprehensive care protocol. Participants undergo extensive lab testing and medical consultations, ensuring a personalized treatment plan throughout the study, which spans a 69-week duration.
At Synergy Groups Medical, we prioritize the well-being of our participants, ensuring a patient-centric approach from enrollment through to study completion. Our researchers and healthcare professionals are certified and well-trained, guaranteeing adherence to the highest standards of safety and efficacy. Enrolled participants can expect frequent clinic visits initially every 2 weeks, transitioning to a 4-week schedule as the study progresses. We understand the involvement may seem significant, but every visit stands as a step closer toward advancing medical research and relief for countless sufferers. To promote ease of participation, our facilities are open Monday through Friday from 8:00 AM to 5:00 PM, allowing for flexible scheduling to accommodate diverse participant commitments.
Joining our study begins with speaking to an Enrollment Specialist who will guide you through the initial eligibility discussion. This is followed by a free pre-screening process to confirm suitability for the study. The well-being of potential participants is a priority, and we ensure they are well-informed and receive a detailed understanding of the study regimen. For those eligible, the journey continues with official enrollment and participation, receiving necessary treatments and attending scheduled visits. Moreover, participants are compensated for their time and effort, acknowledging their contribution to advancing medical science.
For those residing in Houston and Missouri City, Synergy Groups Medical presents an accessible opportunity to be at the cutting edge of innovative medical research. Our centrally located outpatient care centers ensure you can participate without the need to travel long distances. Local involvement not only benefits the participant but also contributes to the general advancement of medical research and the improvement of healthcare solutions within our community.
We at Synergy Groups Medical invite you to be part of a transformative journey in refractory gout research. Your participation is more than just enrollment–it's a step towards potential breakthroughs that could redefine gout treatment. By joining our clinical study, you're helping unlock the future of medical science, providing an opportunity for better management of a condition that affects millions worldwide.
Want to be part of something bigger? Your participation in our clinical study could be the catalyst for a revolutionary change in the treatment of refractory gout. At Synergy Groups Medical, we believe in the potential each participant brings in shaping the future of medical advancements. Take the leap and contribute to solutions that may transform countless lives.
Don't miss your chance to drive impactful change in the realm of medical science. Reach out to us today at Synergy Groups Medical, and begin your journey as a crucial contributor to innovative treatment solutions for refractory gout. To learn more about the study or to discuss your eligibility, contact us at (832) 532-4210 or email info@synergygroupus.com. Together, let's make strides towards a healthier future.
(346) 633-4900 | Extension 4
(346) 633-4900 | Extension 2
3281 Rocky Creek Dr, Missouri City, Texas 77459, United States | Suite 500
(346) 633-4900 | Extension 3